GENETIC-ANALYSIS OF THE COFACTOR REQUIREMENT FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT FUNCTION

被引:123
|
作者
MADORE, SJ
CULLEN, BR
机构
[1] DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,GENET SECT,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT MICROBIOL,DURHAM,NC 27710
关键词
D O I
10.1128/JVI.67.7.3703-3711.1993
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Tat protein of human immunodeficiency virus type 1 is a potent transcriptional trans activator of the viral long terminal repeat promoter element. Tat function requires the direct interaction of Tat with a cis-acting viral RNA target sequence termed the trans-activation response (TAR) element and has also been proposed to require at least one cellular cofactor. We have used a genetic approach to attempt to experimentally define the role of the cellular cofactor in Tat function and TAR binding. Our data suggest that neither Tat nor the cellular cofactor binds to TAR alone in vivo and indicate, instead, that the interaction of Tat with its cellular cofactor is a prerequisite for TAR binding. The known species tropism of lentivirus Tat proteins appears to arise from the fact that not only Tat but also the cellular cofactor can markedly influence the RNA sequence specificity of the resultant protein complex. These data also suggest that the Tat cofactor is likely a cellular transcription factor that has been highly conserved during vertebrate evolution. We hypothesize that the primary function of Tat is to redirect this cellular factor to a novel viral RNA target site and to thereby induce activation of viral gene expression.
引用
下载
收藏
页码:3703 / 3711
页数:9
相关论文
共 50 条
  • [31] TRANSMISSION AND PATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONNOR, RI
    HO, DD
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 321 - 323
  • [32] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF THE BRAIN
    ATWOOD, WJ
    BERGER, JR
    KADERMAN, R
    TORNATORE, CS
    MAJOR, EO
    CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (04) : 339 - 366
  • [33] INACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY ALCOHOLS
    VANBUEREN, J
    LARKIN, DP
    SIMPSON, RA
    JOURNAL OF HOSPITAL INFECTION, 1994, 28 (02) : 137 - 148
  • [34] CELLULAR LATENCY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    POMERANTZ, RJ
    BAGASRA, O
    BALTIMORE, D
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (04) : 475 - 480
  • [35] HEADACHE AND THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    HOLLOWAY, RG
    KIEBURTZ, KD
    HEADACHE, 1995, 35 (05): : 245 - 255
  • [37] RENAL COMPLICATIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    BOURGOIGNIE, JJ
    KIDNEY INTERNATIONAL, 1990, 37 (06) : 1571 - 1584
  • [38] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND CYTOMEGALOVIRUS IN SALIVA
    LUCHT, E
    ALBERT, J
    LINDE, A
    XU, WM
    BRYTTING, M
    LUNDEBERG, J
    UHLEN, M
    BRATT, G
    SANDSTROM, E
    HEIMDAHL, A
    NORD, CE
    WAHREN, B
    JOURNAL OF MEDICAL VIROLOGY, 1993, 39 (02) : 156 - 162
  • [39] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TROPISM FOR HUMAN MACROPHAGES
    COLLMAN, R
    PATHOBIOLOGY, 1992, 60 (04) : 213 - 218
  • [40] THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF GENE - THE ROAD FROM AN ACCESSORY TO AN ESSENTIAL ROLE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION
    VOLSKY, DJ
    POTASH, MJ
    SIMM, M
    SOVA, P
    MA, XY
    CHAO, W
    SHAHABUDDIN, M
    TRANSACTING FUNCTIONS OF HUMAN RETROVIRUSES, 1995, 193 : 157 - 168